These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23443455)

  • 1. Leukemia as a cause of death among patients with myelodysplastic syndromes (MDS) in a population- based cancer registry: improving estimates of MDS-related mortality in the population.
    Polednak AP; Phillips C
    J Registry Manag; 2012; 39(3):115-20. PubMed ID: 23443455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of US deaths related to myelodysplastic syndromes, and the need for linkages with central cancer registries.
    Polednak AP
    J Registry Manag; 2011; 38(4):183-9. PubMed ID: 23270091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend (1999-2009) in U.S. death rates from myelodysplastic syndromes: utility of multiple causes of death in surveillance.
    Polednak AP
    Cancer Epidemiol; 2013 Oct; 37(5):569-74. PubMed ID: 23773300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coding of specific subgroups of myelodysplastic syndromes in a population-based cancer registry: prospects for improvement.
    Polednak AP; Phillips C
    J Registry Manag; 2012; 39(3):107-14. PubMed ID: 23443454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
    Polednak AP
    J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of using multiple causes of death codes to compute site-specific, death certificate-based cancer mortality statistics in the United States.
    Fink AK; German RR; Heron M; Stewart SL; Johnson CJ; Finch JL; Yin D; Schaeffer PE;
    Cancer Epidemiol; 2012 Feb; 36(1):22-8. PubMed ID: 21907006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inaccuracies in oral cavity-pharynx cancer coded as the underlying cause of death on U.S. death certificates, and trends in mortality rates (1999-2010).
    Polednak AP
    Oral Oncol; 2014 Aug; 50(8):732-9. PubMed ID: 24862544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using cancer registries to assess the accuracy of primary liver or intrahepatic bile duct cancer as the underlying cause of death, 1999-2010.
    Polednak AP
    J Registry Manag; 2013; 40(4):168-75. PubMed ID: 24625770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
    Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
    Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
    De Roos AJ; Deeg HJ; Davis S
    Cancer Causes Control; 2007 Dec; 18(10):1199-208. PubMed ID: 17823848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment.
    Cogle CR; Iannacone MR; Yu D; Cole AL; Imanirad I; Yan L; Mackinnon JA; List AF; Rollison DE
    Leuk Res; 2014 Jan; 38(1):71-5. PubMed ID: 24280283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term health experience of jet engine manufacturing workers: IV. A comparison of central nervous system cancer ascertainment using mortality and incidence data.
    Buchanich JM; Youk AO; Marsh GM; Kennedy KJ; Esmen NA; Lacey SE; Hancock R; Cunningham MA; Lieberman FS; Fleissner ML
    Ann Epidemiol; 2010 Oct; 20(10):759-65. PubMed ID: 20816315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.
    Komrokji RS; Matacia-Murphy GM; Al Ali NH; Beg MS; Safa MM; Rollison DE; List AF
    Leuk Res; 2010 Jan; 34(1):59-62. PubMed ID: 19368972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
    Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
    Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia.
    Feldman EJ; Seiter KP; Ahmed T; Baskind P; Arlin ZA
    Leukemia; 1996 Jan; 10(1):40-2. PubMed ID: 8558935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndromes in the United States: an update for clinicians.
    Troy JD; Atallah E; Geyer JT; Saber W
    Ann Med; 2014 Aug; 46(5):283-9. PubMed ID: 24716735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.